Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Tsuji

Showing results (71-80 of 103) with videos related to

Pageof 11
Sort By:
Infectious Diseases (London, England)|January 25, 2017
A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA)Iffat Shafiq, Zackery P Bulman, Sarah L Spitznogle, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
Pharmacokinetics of four different brands of colistimethate and formed colistin in ratsHui He, Ji-Chang Li, Roger L Nation, et al.
JMIR Mhealth and Uhealth|December 18, 2020
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection ModelJustin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
JMIR Mhealth and Uhealth|December 16, 2020
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Scandinavian Journal of Infectious Diseases|November 2, 2012
Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infectionTohru Takata, Motoyasu Miyazaki, Maki Futo, et al.
Scientific Reports|February 7, 2024
Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniaeJan Naseer Kaur, Navaldeep Singh, Nicholas M Smith, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistanceNeang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Jac-Antimicrobial Resistance|July 23, 2025
Combatting mobile colistin-resistant (MCR), metallo-β-lactamase (MBL)-producing <i>Klebsiella pneumoniae</i> persistersJack F Klem, Jan Naseer Kaur, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Pageof 11

Showing results (71-80 of 103) with videos related to

Sort By:
Pageof 11
Infectious Diseases (London, England)|January 25, 2017
A combination of ceftaroline and daptomycin has synergistic and bactericidal activity in vitro against daptomycin nonsusceptible methicillin-resistant Staphylococcus aureus (MRSA)Iffat Shafiq, Zackery P Bulman, Sarah L Spitznogle, et al.
The Journal of Antimicrobial Chemotherapy|June 11, 2013
Pharmacokinetics of four different brands of colistimethate and formed colistin in ratsHui He, Ji-Chang Li, Roger L Nation, et al.
JMIR Mhealth and Uhealth|December 18, 2020
Correction: ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Antimicrobial Agents and Chemotherapy|January 6, 2017
High-Dose Ampicillin-Sulbactam Combinations Combat Polymyxin-Resistant Acinetobacter baumannii in a Hollow-Fiber Infection ModelJustin R Lenhard, Nicholas M Smith, Zackery P Bulman, et al.
JMIR Mhealth and Uhealth|December 16, 2020
ColistinDose, a Mobile App for Determining Intravenous Dosage Regimens of Colistimethate in Critically Ill Adult Patients: Clinician-Centered Design and Development StudyXueliang Hua, Chen Li, Jason M Pogue, et al.
Scandinavian Journal of Infectious Diseases|November 2, 2012
Presence of both heterogeneous vancomycin-intermediate resistance and β-lactam antibiotic-induced vancomycin resistance phenotypes is associated with the outcome in methicillin-resistant Staphylococcus aureus bloodstream infectionTohru Takata, Motoyasu Miyazaki, Maki Futo, et al.
Scientific Reports|February 7, 2024
Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniaeJan Naseer Kaur, Navaldeep Singh, Nicholas M Smith, et al.
The Journal of Antimicrobial Chemotherapy|February 26, 2015
Colistin and doripenem combinations against Pseudomonas aeruginosa: profiling the time course of synergistic killing and prevention of resistanceNeang S Ly, Jürgen B Bulitta, Gauri G Rao, et al.
Jac-Antimicrobial Resistance|July 23, 2025
Combatting mobile colistin-resistant (MCR), metallo-β-lactamase (MBL)-producing <i>Klebsiella pneumoniae</i> persistersJack F Klem, Jan Naseer Kaur, Yang Liu, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2015
Two mechanisms of killing of Pseudomonas aeruginosa by tobramycin assessed at multiple inocula via mechanism-based modelingJürgen B Bulitta, Neang S Ly, Cornelia B Landersdorfer, et al.
Pageof 11